These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

339 related items for PubMed ID: 19085805

  • 1. [Rheology and coronary heart disease].
    Leschke M.
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 8():S270-3. PubMed ID: 19085805
    [Abstract] [Full Text] [Related]

  • 2. [Hemorheologic therapy applications in coronary heart disease].
    Leschke M, Motz W, Strauer BE.
    Wien Med Wochenschr; 1986 Dec; 136 Spec No():17-24. PubMed ID: 3825169
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Effect of therapeutic plasmapheresis on rheological properties of blood in patients with ischemic heart disease].
    Zadionchenko VS, Bezprozvannyĭ AB, Dzhanashiia PKh, Romashkin AV, Kuznetsova EIu, Borzova LV, Dobashina AN.
    Sov Med; 1991 Dec; (10):3-6. PubMed ID: 1801230
    [Abstract] [Full Text] [Related]

  • 5. [Rheologic changes in the postprandial phase].
    Leschke M, Saddig C, Kleophas W, Toeller M, Reinauer H, Strauer BE.
    Klin Wochenschr; 1990 Dec; 68 Suppl 22():89-94. PubMed ID: 2087087
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Fibrinogen as a risk factor for coronary heart disease.
    Montalescot G, Collet JP, Choussat R, Thomas D.
    Eur Heart J; 1998 Jul; 19 Suppl H():H11-7. PubMed ID: 9717059
    [Abstract] [Full Text] [Related]

  • 8. [Hemorrheological changes in ischemic heart disease].
    Forconi S, Guerrini M, Pieragalli D, Acciavatti A, Del Bigo C, Galigani C, Di Perri T.
    Ric Clin Lab; 1983 Jul; 13 Suppl 3():195-208. PubMed ID: 6672996
    [Abstract] [Full Text] [Related]

  • 9. Effect of hormone replacement therapy upon haemorheological variables.
    Spengler MI, Goñi GM, Mengarelli G, Bravo Luna M, Bocanera R, Tozzini R, Rasia ML.
    Clin Hemorheol Microcirc; 2003 Jul; 28(1):13-9. PubMed ID: 12632008
    [Abstract] [Full Text] [Related]

  • 10. [The significance of rheologic mechanisms in atherogenesis].
    Leschke M, Strauer BE.
    Arzneimittelforschung; 1990 Mar; 40(3A):356-62. PubMed ID: 2185764
    [Abstract] [Full Text] [Related]

  • 11. Blood fluidity, fibrinogen, and cardiovascular risk factors of occlusive arterial disease: results of the Aachen study.
    Koscielny J, Jung EM, Mrowietz C, Kiesewetter H, Latza R.
    Clin Hemorheol Microcirc; 2004 Mar; 31(3):185-95. PubMed ID: 15322324
    [Abstract] [Full Text] [Related]

  • 12. [Blood viscosity and myocardial microcirculation].
    Kochmański M, Zochowski RJ.
    Kardiol Pol; 1990 Mar; 33(11-2):64-70. PubMed ID: 2096255
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of fibrinogen and alpha2-macroglobulin and their apheretic elimination on general blood rheology and rheological characteristics of red blood cell aggregates.
    Kirschkamp T, Schmid-Schönbein H, Weinberger A, Smeets R.
    Ther Apher Dial; 2008 Oct; 12(5):360-7. PubMed ID: 18937718
    [Abstract] [Full Text] [Related]

  • 15. [Chronic intermittent urokinase therapy in therapy-refractory angina pectoris].
    Leschke M, Höffken H, Motz W, Blanke H, Schöbel F, Strauer BE.
    Dtsch Med Wochenschr; 1992 Jan 17; 117(3):81-7. PubMed ID: 1730212
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Chronic intermittent urokinase therapy in inoperable end-stage coronary disease with therapy refractory angina pectoris symptoms].
    Leschke M, Mecklenbeck W, Strauer BE.
    Med Klin (Munich); 1992 Jul 15; 87(7):385-9. PubMed ID: 1508119
    [No Abstract] [Full Text] [Related]

  • 19. Erythrocyte apheresis in combination with elimination of fibrinogen and plasma proteins of higher molecular weight in macular disease and in uveal effusion syndrome.
    Brunner R, Borberg H, Kadar J, Heidel M, Heidner K, Konen W.
    Acta Med Austriaca; 1991 Jul 15; 18 Suppl 1():63-5. PubMed ID: 1950392
    [Abstract] [Full Text] [Related]

  • 20. Involvement of erythrocyte aggregation and erythrocyte resistance to flow in acute coronary syndromes.
    Pfafferott C, Moessmer G, Ehrly AM, Bauersachs RM.
    Clin Hemorheol Microcirc; 1999 Jul 15; 21(1):35-43. PubMed ID: 10517486
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.